In the fourth edition of our new special newsletter SCHLAGLICHT – New Drugs for Dementia, Florian Weidinger, research associate at digiDEM Bayern, deals with the publication "The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer’s disease: an EADC-EC viewpoint" by the research team led by Professor Linus Jönsson from the Karolinska Institutet in Sweden. In the journal The Lancet…
At the 12th Congress of the German Alzheimer Society in the Stadthalle of Fürth/Bavaria, digiDEM Bavaria was not only represented with its own booth but also with a scientific symposium led by Prof. Dr. med. Elmar Gräßel, head of the Center for Medical Research at the University Hospital Erlangen and project manager of digiDEM…
In the third issue of our new special newsletter "SCHLAGLICHT – New Medications for Dementia," Dr. Nikolas Dietzel, a research associate at digiDEM Bayern, discusses the publication by scientists from Europe, the USA, and Australia, led by Professor Poul F. Høilund-Carlsen from Odense University Hospital in Denmark. In the article titled "Donanemab, another anti-Alzheimer’s…"
Most people in need of care long for a home that allows them the greatest possible freedom and independence. Shared living arrangements with outpatient care are another option for people with dementia who can no longer live independently at home. This is especially true when moving to a residential care facility is not desired. In …
Dementias can be associated with an increased urge to move, which can pose certain dangers. When people with cognitive impairments leave their homes and wander outdoors, their risk of fractures or other injuries increases. This is a very worrying situation for caregivers. To what extent the still young technology...
Korean researchers investigated whether there is a connection between migraines and dementia. After analyzing data from more than 11,000 dementia patients and over 45,700 control subjects, they found that women with a history of migraines have an increased risk of dementia. Generally, there is increasing evidence that women and men experience different...
Certain neuropsychiatric symptoms, such as depression and psychosis, occur more frequently in women with Alzheimer's dementia than in men with Alzheimer's dementia. This is one of the central findings of a study by researchers from the Netherlands, Sweden, the USA, Canada, and Australia. In people with Alzheimer's dementia (AD), neuropsychiatric...
Not only consider dementia risk, but also analyze protective factors that reduce the risk of Alzheimer's dementia: Researchers from Canada and Sweden have investigated whether there are gender-specific differences regarding the so-called cognitive reserve. There is frequent discussion of risk factors that can promote the development of Alzheimer's dementia (AD). „Factors that the AD risk..."
In the second part of our new special newsletter, SCHLAGLICHT – New Dementia Medications, Jana Rühl, a research associate at digiDEM Bavaria, discusses the publication by the research team led by Professor Sören Mattke from the University of Southern California. Today, we address the question of whether healthcare systems can even cope with the diagnostic requirements...
Is forgetfulness in old age normal? Or is it a sign of dementia? In conjunction with the 5th Bavarian Dementia Week, taking place from September 20th to September 29th, 2024, digiDEM Bayern is once again drawing attention to the increasingly important topic of early dementia detection. Around Dementia Week, the scientists at digiDEM Bayern have organized a total of 17 dementia screening days...
